Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID‐19: A multi‐center, open‐label, randomized controlled trial
Journal of thrombosis and haemostasis : JTH (2021) - Comments
doi: 10.1111/jth.15450  issn: 1538-7933  issn: 1538-7836  pubmed: 34236768 

Usha S. Perepu, Isaac Chambers, Abdul Wahab, Patrick Ten Eyck, Chaorong Wu, Sanjana Dayal, Grerk Sutamtewagul, Steven R. Bailey, Lori J. Rosenstein, Steven R. Lentz